LOX and cancer: Other analyses indicated that LOX overexpression correlates with epithelial-mesenchymal transition (EMT) (Figure 4E and 4F) and activation of cancer stem cell pathways, such as the WNT and HEDGEHOG pathways (Figure 4G–4I).